Navigation Links
Terrosa Technologies Assigned as Exclusive Reseller for Inclinicalperform CTMS/SaaS Clinical Trials Collaboration Software
Date:8/1/2009

Terrosa Technologies, a provider of Cloud and SaaS migration services and SaaS based applications, announces it has exclusive world wide sales, marketing and distribution responsibilities with Integrated Clinical Solutions for its Inclinicalperform application. Inclinicalperform is software-as-a-subscription (SaaS) based collaboration Clinical Trial Management System (CTMS) tool for the pharmaceutical clinical research community to reduce both costs and effort in tracking, monitoring and aggregating information that is created during the clinical trials process.

Thousand Oaks, CA (PRWEB) August 1, 2009 -- Terrosa Technologies, a provider of Cloud and SaaS migration services and SaaS based applications, announces it has exclusive world wide sales, marketing and distribution responsibilities with Integrated Clinical Solutions for its inclinicalperform application. Inclinicalperform is software-as-a-subscription (SaaS) based collaboration Clinical Trial Management System (CTMS) tool for the pharmaceutical clinical research community to reduce both costs and effort in tracking, monitoring and aggregating information that is created during the clinical trials process.

With this agreement, Terrosa will have exclusive responsibility to for the sales and marketing of Integrated Clinical Solutions' Inclinicalperform Terrosa Technologies, LLC will develop the go-to-market strategies as well operations for sales, marketing and support for inclinicalperform This partnership expands on Terrosa's successful SaaS software conversion services and will speed time to market for independent software vendors (ISVs) such as Integrated Clinical Solutions. "We are pleased to partner with Integrated Clinical Solutions so that they may maintain their focus on further development and roadmap to incorporating new process automations within inclinicalperform" said Kim Terry, President of Terrosa Technologies.

inclinicalperform's collaboration software platform will benefit the clinical research community by taking much of the manual work out of tracking, monitoring and aggregating information that is created during the clinical trials process. "Our software makes the clinical operations job easier by providing a consistent collaborative work process that is straightforward and self documenting", said Inclinical's founder J. Peter Armerding, "Terrosa's integrated services will allow us to do what we do best - Clinical Operations Process Automation".

Terrosa Technologies (www.terrosatech.com) specializes in the migration of on premise applications into subscription based services to drive down costs and make high quality software more available to companies of all sizes. "Response for this type of comprehensive service has been tremendous because of the Return on Investment and Total Cost of Ownership benefits," states Terrosa President, Kim Terry. "We work with software companies who have domain expertise, turning them into SaaS providers with a powerful marketing and sales program."

About Terrosa Technologies:

Terrosa technology is an early innovator in working with software developers who need assistance to take their application to the SaaS environment and in providing go-to-market planning and Sales and Marketing operations. In addition, Terrosa Technologies also achieves positive results for our customers in transition in-house systems to Software as a Service delivered systems, Platform as a Service, or other technologies collectively known as Cloud Computing. Enormous efficiencies are expected to quickly drive down the cost of application programs for everyone using this technology.

About Integrated Clinical Solutions:

Integrated Clinical Solutions, Inc. (www.inclinical.com) creates software exclusively for clinical trial operations organizations. We bring process automation to clinical operations in the pharmaceutical, biotechnology and medical device industries. After encountering all the difficulties of implementing other leading clinical software programs, we realized that the cost of implementation and lost time for stakeholders to learn new programs was a large hurdle to overcome when you bring new systems online. We designed our software to be implemented quickly and easily understood by clinical operations end users.

###

Read the full story at http://www.prweb.com/releases/2009/08/prweb2702264.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Senesco Technologies Enters Into Agreements For Additional $700,000 In Financing
2. Debiopharm and MSM Protein Technologies Sign Agreement for Research and Development of Debio 0929, a Novel Oncology Biologic
3. Ricardo Launches Consortium to Evaluate Lubricant Challenges of Future Low Carbon Engine Technologies
4. BioSpecifics Technologies Corp. to Present at CapStone Investments Third Annual Small-Cap Investor Conference
5. DNA Software, Inc. Awarded $2.5 M in NIH Funding to Develop Pioneering Nucleic Acid-based Technologies
6. 4th BTLtec Conference on 24-25 Sep in Graz, Austria features Biomass to Liquids Innovators Sharing Updates on Pyrolysis and Gasification Technologies, Syngas Application, BTL Value Chain and a Site Visit to the Biomass CHP Gussing Plant.
7. Champions Biotechnology Partners with Do-Coop Technologies to Advance Its Novel Oncology Compound Into Biomerk Tumorgraft(TM) Testing
8. Supelco(R) and MIP Technologies Launch New SPE Product for the Selective Extraction of NSAIDs From Environmental Water
9. ImmunoVaccine Technologies Licenses Immunotopes Breast, Ovarian and Prostate Cancer Antigens
10. Senesco Technologies Enters Into Agreement For Up To $1.0 Million In Financing
11. Harvest Technologies Announces Completion of Patient Enrollment in its 60 Patient Clinical Trial in India Using Autologous Adult Stem Cells to Treat Patients With Non-Reconstructable Critical Limb Ischemia
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Terrosa Technologies Assigned as Exclusive Reseller for Inclinicalperform CTMS/SaaS Clinical Trials Collaboration Software
(Date:4/29/2016)... ... 2016 , ... Proove Biosciences, Inc ., the commercial ... of the Proove Health Foundation . The Foundation is a non-profit organization ... of personalized medicine for tackling the nation’s most-pressing healthcare epidemics. As part of ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... necessary fundamentals to transform technology into a viable company, CereScan’s CEO, John Kelley, ... Mr. Kelley, a recognized leader and mentor in the Denver area business community, ...
(Date:4/29/2016)... Elekta is pleased to announce ... industry-leading treatment planning software, is available for clinical release. ... version 5.11 provides significant performance speed enhancements over ... to four times faster than in previous versions of ... standard Monte Carlo algorithm, users ...
(Date:4/28/2016)... ... April 28, 2016 , ... Connecticut Innovations ... growing companies, today announced the launch of VentureClash , a $5 million ... , “VentureClash looks to attract the best early-stage companies here in Connecticut, ...
Breaking Biology Technology:
(Date:3/9/2016)... March 9, 2016  Crossmatch ® , a ... solutions, today announced the addition of smart features ... multi-factor authentication platform. New contextual and application-specific ... step-up security where it,s needed most — while ... DC . --> Washington, ...
(Date:3/3/2016)... -- FlexTech, a SEMI Strategic Association Partner, awarded five FLEXI ... Leadership in Education, and, in a category new this ... year of the FLEXI Awards and the winners join ... past years . Judging was done on a set ... by a panel of non-affiliated, independent, industry experts. ...
(Date:3/3/2016)... DE SOTO, Kansas , March 3, 2016 /PRNewswire/ ... offer Oncimmune,s Early CDT®-Lung, a blood test to ... lung cancer Early CDT®-Lung test to its ... --> Early CDT®-Lung test to its clients which ... Oncimmune, a leader in early cancer detection, today announced ...
Breaking Biology News(10 mins):